Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and sysemic lupus erythematosus

Arthritis Research and Therapy

Volumn 12, Issue 3, 2010, Pages

  Nagy, György ^a   Koncz, Agnes ^a   Telarico, Tiffany ^b   Fernandez, David ^b   Érsek, Barbara ^a   Buzás, Edit ^a   Perl, András ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; MAMMALIAN TARGET OF RAPAMYCIN; NITRIC OXIDE; T LYMPHOCYTE RECEPTOR; ADENOSINE TRIPHOSPHATE;

GLUTATHIONE METABOLISM; HUMAN; LYMPHOCYTE DIFFERENTIATION; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; ARTHRITIS, RHEUMATOID; GLUTATHIONE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NITRIC OXIDE; T-LYMPHOCYTES;

EID: 78650691031     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3045     Document Type: Review

References (67)

1. Brown CG. Nitric oxide and mitochondrial respiration. Biochem Biophys Acta 1999, 1411:351-369. 10.1016/S0005-2728(99)00025-0, 10320668.
2. Beltrán B, Mathur A, Duchen MR, Erusalimsky JD, Moncada S. The effect of nitric oxide on cell respiration: a key to undertanding its role in cell survival or death. Proc Natl Acad Sci USA 2000, 97:14602-14607. 10.1073/pnas.97.26.14602, 11121062, 18965.
3. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288:373-376. 10.1038/288373a0, 6253831.
4. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526. 10.1038/327524a0, 3495737.
5. Bredt DS. Endogenous nitrice oxide synthesis: biological functions and pathophysiology. Free Radic Res 1999, 31:577-596. 10.1080/10715769900301161, 10630682.
6. Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 2001, 282:1075-1079. 10.1006/bbrc.2001.4670, 11302723.
7. Beltrán B, Quintero M, Gracia-Zaragoza E, O'Connor E, Esplugues JV, Moncada S. Inhibition of mitochondrial respiration by endogenous nitric oxide: a critical step in Fas signalling. Proc Natl Acad Sci USA 2002, 99:8892-8897. 10.1073/pnas.092259799, 12077295, 124394.
8. Kim YM, Bombeck CA, Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 1999, 84:253-256.
9. Nisoli E, Clementi E, Paolucci C. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003, 299:896-899. 10.1126/science.1079368, 12574632.
10. Nagy G, Barcza M, Gonchoroff N, Phillips PE, Perl A. Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells. J Immunol 2004, 173:3676-3683.
11. Mallis RJ, Buss JE, Thomas JA. Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. Biochem J 2001, 355:145-153. 1221722, 11256959, 10.1042/0264-6021:3550145.
12. Gow AJ, Farkouh CR, Munson DA, Posencheg MA, Ischiropoulos H. Biological significance of nitric oxide-mediated protein modifications. Am J Physiol Lung Cell Mol Physiol 2004, 287:L262-268. 10.1152/ajplung.00295.2003, 15246980.
13. Nagy G, Koncz A, Perl A. T cell activation-induced mitochondrial hyperpolarization is mediated by Ca2+- and redox-dependent production of nitric oxide. J Immunol 2003, 171:5188-5197.
14. Ibiza S, Víctor VM, Boscá I, Ortega A, Urzainqui A, O'Connor JE, Sánchez-Madrid F, Esplugues JV, Serrador JM. Endothelial nitric oxide synthase regulates T cell receptor signaling at the immunological synapse. Immunity 2006, 24:753-765. 10.1016/j.immuni.2006.04.006, 16782031.
15. Skapenko A, Leipe J, Lipsky PE, Schulze-Koops H. The role of the T cell in autoimmune inflammation. Arthritis Res Ther 2005, 7(Suppl 2):S4-14. 2833981, 15833146, 10.1186/ar1703.
16. Niedbala W, Wei XQ, Campbell C, Thomson D, Komai-Koma M, Liew FY. Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP. Proc Natl Acad Sci USA 2002, 99:16186-16191. 138586, 12451176, 10.1073/pnas.252464599.
17. Koncz A, Pasztoi M, Mazan M, Fazakas F, Buzas E, Falus A, Nagy G. Nitric oxide mediates T cell cytokine production and signal transduction in histidine decarboxylase knockout mice. J Immunol 2007, 179:6613-6619.
18. Oates JC, Shaftman SR, Self SE, Gilkeson GS. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Arthritis Rheum 2008, 58:263-272. 2733831, 18163495, 10.1002/art.23153.
19. Nagy G, Koncz A, Philips PE, Perl A. Mitochondrial signal transduction abnormalities in systemic lupus erythematosus. Curr Immunol Rev 2005, 1:61-67.
20. Perl A. Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol 2009, 21:443-447. 10.1097/BOR.0b013e32832efe6b, 19584730.
21. Perl A, Fernandez DR, Telarico T, Doherty E, Francis L, Phillips PE. T-cell and B-cell signaling biomarkers and treatment targets in lupus. Curr Opin Rheumatol 2009, 21:454-464. 10.1097/BOR.0b013e32832e977c, 19550330.
22. Vassilopoulos D, Kovacs B, Tsokos GC. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J Immunol 1995, 155:2269-2281.
23. Perl A, Gergely P, Nagy G, Koncz A, Banki K. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol 2004, 25:360-367. 10.1016/j.it.2004.05.001, 15207503.
24. Perl A, Nagy G, Gergely P, Puskas F, Qian Y, Banki K. Apoptosis and mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods Mol Med 2004, 102:87-114.
25. Kammer GM, Perl A, Richardson BC, Tsokos GC. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum 2002, 46:1139-1154. 10.1002/art.10192, 12115215.
26. Rizutto R, Duchen MR, Pozzan T. Flirting in little space: the ER/mitochondria Ca2+ liaison. Sci STKE 2004, (215):re1.
27. Nagy G, Clark JM, Buzas E, Gorman C, Pasztoi M, Koncz A, Falus A, Cope AP. Nitric oxide production of T lymphocytes is increased in rheumatoid arthritis. Immunol Lett 2008, 118:55-58. 10.1016/j.imlet.2008.02.009, 18396335.
28. Gergely P, Grossman C, Niland B, Puskas F, Neupane H, Allam F, Banki K, Phillips PE, Perl A. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum 2002, 46:175-190. 10.1002/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H, 11817589.
29. Fernandez DR, Telarico T, Bonilla E, Li Q, Banerjee S, Middleton FA, Phillips PE, Crow MK, Oess S, Muller-Esterl W, Perl A. Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. J Immunol 2009, 182:2063-2073. 2676112, 19201859, 10.4049/jimmunol.0803600.
30. Banki K, Hutter E, Gonchoroff NJ, Perl A. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J Immunol 1999, 162:1466-1479.
31. Bauer JW, Petri M, Batliwalla FM, Koeuth T, Wilson J, Slattery C, Panoskaltsis-Mortari A, Gregersen PK, Behrens TW, Baechler EC. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study. Arthritis Rheum 2009, 60:3098-3107. 2842939, 19790071, 10.1002/art.24803.
32. Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004, 18:1926-1945. 10.1101/gad.1212704, 15314020.
33. Nagy G, Ward J, Mosser DD, Koncz A, Gergely P, Stancato C, Qian Y, Fernandez D, Niland B, Grossman CE, Telarico T, Banki K, Perl A. Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection. J Biol Chem 2006, 281:34574-34591. 10.1074/jbc.M606301200, 16935861.
34. Kirchgessner H, Dietrich J, Scherer J, Isomäki P, Korinek V, Hilgert I, Bruyns E, Leo A, Cope AP, Schraven B. The transmembrane adaptor protein TRIM regulates T cell receptor (TCR)expression and TCR-mediated signaling via an association with the TCR zeta chain. J Exp Med 2001, 193:1269-1284. 2193385, 11390434, 10.1084/jem.193.11.1269.
35. Liossis SNC, Ding XZ, Dennis GJ, Tsokos GC. Altered pattern of TCR/CD3 mediated protein tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus: deficient expression of the T cell receptor zeta chain. J Clin Invest 1998, 101:1448-1457. 508723, 9525988, 10.1172/JCI1457.
36. Brundula V, Rivas LJ, Blasini AM, París M, Salazar S, Stekman IL, Rodríguez MA. Diminished levels of T cell receptor ζ chains in peripheral blood T lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum 1999, 42:1908-1916. 10.1002/1529-0131(199909)42:9<1908::AID-ANR17>3.0.CO;2-7, 10513807.
37. Nambiar MP, Mitchell JP, Ceruti RP, Mally MA, Tsokos GC. Prevalence of T cell receptor zeta chain deficiency in systemic lupus erythematosus. Lupus 2003, 12:46-51. 10.1191/0961203303lu281oa, 12587826.
38. Nambiar MP, Enyedi EJ, Fisher CU, Warke VG, Juang YT, Tsokos GC. Dexamethasone modulates TCR zeta chain expression and antigen receptor-mediated early signaling events in human T lymphocytes. Cell Immunol 2001, 208:62-71. 10.1006/cimm.2001.1761, 11277620.
39. Nambiar MP, Enyedy EJ, Warke VG, Krishnan S, Dennis G, Wong HK, Kammer GM, Tsokos GC. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA. Arthritis Rheum 2001, 44:1336-1350. 10.1002/1529-0131(200106)44:6<1336::AID-ART226>3.0.CO;2-8, 11407693.
40. Juang YT, Tenbrock K, Nambiar MP, Gourley MF, Tsokos GC. Defective production of functional 98-kDa form of Elf-1 is responsible for the decreased expression of TCR zeta-chain in patients with systemic lupus erythematosus. J Immunol 2002, 169:6048-6055.
41. Tenbrock K, Kyttaris VC, Ahlmann M, Ehrchen JM, Tolnay M, Melkonyan H, Mawrin C, Roth J, Sorg C, Juang YT, Tsokos GC. The cyclic AMP response element modulator regulates transcription of the TCR zeta-chain. J Immunol 2005, 175:5975-5980.
42. Chowdhury B, Tsokos CG, Krishnan S, Robertson J, Fisher CU, Warke RG, Warke VG, Nambiar MP, Tsokos GC. Decreased stability and translation of T cell receptor zeta mRNA with an alternatively spliced 3'-untranslated region contribute to zeta chain down-regulation in patients with systemic lupus erythematosus. J Biol Chem 2005, 280:18959-18966. 10.1074/jbc.M501048200, 15743765.
43. Krishnan S, Juang YT, Chowdhury B, Magilavy A, Fisher CU, Nguyen H, Nambiar MP, Kyttaris V, Weinstein A, Bahjat R, Pine P, Rus V, Tsokos GC. Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells. J Immunol 2008, 181:8145-8152. 2586973, 19018007.
44. Moulton VR, Tsokos GC. Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptorassociated CD3 complex. J Biol Chem 2010, 285:12490-12496. 10.1074/jbc.M109.091660, 20118245.
45. Farrell AJ, Blake DR, Palmar RMJ. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992, 51:1219-1222. 1012459, 1466599, 10.1136/ard.51.11.1219.
46. Pham TN, Rahman P, Tobin YM, Khraishi MM, Hamilton SF, Alderdice C, Richardson VJ. Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase and protein kinase C-eta in peripheral blood monocytederived macrophages. J Rheumatol 2003, 30:2529-2534.
47. Onur O, Akinci AS, Akbiyik F, Unsal I. Elevated levels of nitrate in rheumatoid arthritis. Rheumatol Int 2001, 20:154-158. 10.1007/s002960100105, 11411960.
48. Choi JW. Nitric oxide production is increased in patients with rheumatoid arthritis but does not correlate with laboratory parameters of disease activity. Clin Chim Acta 2003, 336:83-87. 10.1016/S0009-8981(03)00324-3, 14500038.
49. Gonzalez-Gay MA, Llorca J, Sanchez E, Lopez-Nevot MA, Amoli MM, Garcia-Porrua C, Ollier WE, Martin J. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. Rheumatology (Oxford) 2004, 43:1182-1185. 10.1093/rheumatology/keh283, 15226517.
50. Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS. Kelley's Textbook of Rheumatology 2005, Elsevier, Saunders, 7.
51. van't Hof RJ, Ralston SH. Nitric oxide and bone. Immunology 2001, 103:255-261. 1783253, 11454054, 10.1046/j.1365-2567.2001.01261.x.
52. Nagy G, Clark JM, Buzás EI, Gorman CL, Cope AP. Nitric oxide, chronic inflammation and autoimmunity. Immunol Lett 2007, 111:1-5. 10.1016/j.imlet.2007.04.013, 17568690.
53. McCartney-francis N, Allen BJ, Mizel DE. Suppression of arthritis by an inhibitor of nitrice oxide synthase. J Exp Med 1993, 178:749-754. 2191124, 7688035, 10.1084/jem.178.2.749.
54. van't Hof RJ, Armour KJ, Smith LM, Armour KE, Wei XQ, Liew FY, Ralston SH. Requirement of the inducible nitric oxide synthase pathway for IL-1- induced osteoclastic bone resorption. Proc Natl Acad Sci USA 2000, 97:7993-7998. 16658, 10869429, 10.1073/pnas.130511497.
55. Perkins DJ, St Clair EW, Misukonis MA, Weinberg JB. Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2). Arthritis Rheum 1998, 41:2205-2210. 10.1002/1529-0131(199812)41:12<2205::AID-ART16>3.0.CO;2-Q, 9870877.
56. Wang B, Ma L, Tao X, Lipsky PE. Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. Arthritis Rheum 2004, 50:2995-2303. 10.1002/art.20459, 15457469.
57. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. Intracellular adenisine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997, 185:1481-1486. 2196283, 9126928, 10.1084/jem.185.8.1481.
58. Melino G, Catani MV, Corazzari M, Guerrieri P, Bernassola F. Nitric oxide can inhibit apoptosis or switch it into necrosis. Cell Mol Life Sci 2000, 57:612-622. 10.1007/PL00000723, 11130461.
59. Maurice MM, Nakamura H, van der Voort EA, van Vliet AI, Staal FJ, Tak PP, Breedveld FC, Verweij CL. Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol 1997, 158:1458-1465.
60. Verweij CL, Gringhuis SI. Oxidants and tyrosine phosphorylation: role of acute and chronic oxidative stress in T-and B-lymphocyte signaling. Antioxid Redox Signal 2002, 4:543-551. 10.1089/15230860260196344, 12215222.
61. Matsuda M, Ulfgren AK, Lenkei R, Petersson M, Ochoa AC, Lindblad S, Andersson P, Klareskog L, Kiessling R. Decreased expression of signaltransducing CD3 zeta chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients. Scand J Immunol 1998, 47:254-262. 10.1046/j.1365-3083.1998.00296.x, 9519864.
62. Isomäki P, Panesar M, Annenkov A, Clark JM, Foxwell BM, Chernajovsky Y, Cope AP. Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface. J Immunol 2001, 166:5495-5507.
63. Clark JM, Annenkov AE, Panesar M, Isomaki P, Chernajovsky Y, Cope AP. T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alpha. Proc Natl Acad Sci USA 2004, 101:1696-1701. 341820, 14745016, 10.1073/pnas.0308231100.
64. Krishnan S, Warke VG, Nambiar MP, Tsokos GC, Farber DL. The FcR gamma subunit and Syk kinase replace the CD3 zeta-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells. J Immunol 2003, 170:4189-4195.
65. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L, Shevach EM, O'shea JJ. Interleukin-2 signaling via STAT5 constrains T Helper 17 cell generation. Immunity 2007, 26:371-381. 10.1016/j.immuni.2007.02.009, 17363300.
66. Bettelli E, Oukka M, Kuchroo VK. Th-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007, 8:345-350. 10.1038/ni0407-345, 17375096.
67. Niedbala W, Cai B, Liu H, Pitman N, Chang L, Liew FY. Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40. Proc Natl Acad Sci USA 2007, 104:15478-15483. 1978217, 17875988, 10.1073/pnas.0703725104.